Burfiralimab
Product Specifications
CAS Number
2460809-80-5
Target
SARS-CoV, Interleukin, HBV
Related Pathways
Microbiology/Virology, Immunology/Inflammation
Purity
0.952
Bioactivity
Burfiralimab (hzVSF-v13) is a monoclonal immunoglobulin (IgG4) targeted against waveform proteins, exhibiting anti-HBV properties and potential applications in rheumatoid arthritis research.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
